Tiformin

Tiformin

SCHEMBL7440384

N=C(N)NCCCC(N)=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
F2 P00734 6/20 0.39
TMPRSS6 Q8IU80 3/20 0.39
ALOX15 P16050 1/20 0.39
CYP1A2 P05177 1/20 0.38
NPY4R P50391 1/20 0.37
CA3 P07451 2/20 0.36
CA5A P35218 2/20 0.36
CA5B Q9Y2D0 2/20 0.36
CA12 O43570 1/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6762936 0.95 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
Synthalin SCHEMBL29526432 0.89 MEN1 (0.52) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
Tiformin SCHEMBL828055 0.86 ALOX15 (0.47) SMN1; SMN2ALDH1A1MEN1KMT2AALOX15
Trifluoroacetic Acid SCHEMBL6761035 0.86 PRMT1 (0.48) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
Trifluoroacetic Acid SCHEMBL3444104 0.85 HDAC6 (0.42) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
Tiformin SCHEMBL9772228 0.84 ALOX15 (0.46) SMN1; SMN2ALDH1A1MEN1KMT2AALOX15
Agmatine SCHEMBL23364182 0.84 PAOX (0.44) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
Trifluoroacetic Acid SCHEMBL23796915 0.82 KDM4E (0.50) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
Trifluoroacetic Acid SCHEMBL4388552 0.82 KDM4E (0.45) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
SCHEMBL437938 0.80 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0577775-A4 ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES. RHONE POULENC RORER INT (US) 1995-01-11 EP disclosed
EP-0577775-A1 ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1994-01-12 EP disclosed
WO-1992017196-A1 ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-10-15 WO disclosed